0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Aducanumab Launch Insight 2019 to 2022
Published Date: February 2019
|
Report Code: DELV-Laun-41
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
Global Aducanumab Launch Insight 2019 to 2022

Global Aducanumab Launch Insight 2019 to 2022

Code: DELV-Laun-41
Report
February 2019
50 Pages
Delveinsight
Region: Global,
Description
Table of Content
Tables & Figures

DelveInsight’s, “Aducanumab, Launch Insight, 2019” report provides comprehensive Insight about the Aducanumab's launch. The report covers all the indications for which the Aducanumab is being developed and also provides the competitive landscape for the major indications. The report further includes patent details, forecasted sales till 2022 and post launch market positioning.

The report will provide a clear picture of market positioning of the upcoming launch of Aducanumab and will also provide the insight about how Aducanumab will evolve in the market as well as within its respective class.Report provides detailed information of clinical trials that have been or are being conducted for this product. Analysis and Insightful information around the clinical trials is provided by assessment of the trial results.
Attribute analysis carried out by our analysts helps in understanding how the upcoming launch scores itself in comparison to other competitors (both marketed and pipeline). The scoring and analysis has been based upon scrutinizing data from all key clinical trials for the product. A head to head comparison with marketed products if available is scanned thoroughly. Further, analyzing data of other competitors with regards to the product also assists in proper scoring of the product in its space.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.
Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Scope

• Detailed product description including its chemical properties, molecule type and mechanism of action
• Detailed description of non-clinical and clinical studies for all the indications
• Patent expiry analysis of the drug along with other competitors in the market
• Forecasted sales till 2022
• Aducanumab market positioning analysis
• Aducanumab class share evolution

Report Introduction
Aducanumab Overview
Aducanumab of action
Pre-clinical Characterization
• Indication 1
• Indication 2
Clinical Characterization
• Indication 1
• Indication 2
Product Developmental Activities
• Collaboration
• Mergers & Acquisitions
• Financing
Aducanumab Market Evolution
Aducanumab Class Share Evolution
Aducanumab Market Positioning
Patent Expiry Analysis
Competitive Landscape for the Aducanumab in major indications
Appendix

List of Tables

Table 1: Aducanumab, Heat Map
Table 2: Clinical Trial Landscape
Table 3: Clinical Efficacy Data from Cross Trials
Table 4: Competitive Landscape for Aducanumab in Indication 1
Table 5: Competitive Landscape for Aducanumab in Indication 2

List of Figures

Figure 1: Aducanumab Developmental Milestones
Figure 2: Aducanumab Sales Forecast till 2023
Figure 3: Aducanumab Class Share Evolution
Figure 4: Comparative analysis of Aducanumab with marketed products in the same class
Figure 5: Patent Expiry Analysis

SELECT A FORMAT
Added to Cart

Electronic (PDF)
$1500
This license allows only one user to access the PDF.

Electronic (PDF)
$3000
This license allows all the users of an enterprise residing in one location to access the PDF

Electronic (PDF)
$4500
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Samsung SD

RELATED REPORTS

Global Cytotoxicity Assay Market Size Status and Forecast 2021 2027
Global Cytotoxicity Assay Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-39V907
Sun Jul 18 00:00:00 UTC 2021

Add to Cart

Global Aquaculture Vaccine Market Size Status and Forecast 2021 2027
Global Aquaculture Vaccine Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-3I3192
Sun Jul 18 00:00:00 UTC 2021

Add to Cart

Global Intranasal Corticosteroids Market Size Status and Forecast 2021 2027
Global Intranasal Corticosteroids Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-25X2634
Sun Jul 18 00:00:00 UTC 2021

Add to Cart

Global Tumor Tracking System Market Size Status and Forecast 2021 2027
Global Tumor Tracking System Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-21F2812
Sun Jul 18 00:00:00 UTC 2021

Add to Cart